Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

Variant Study in the Introns 1 and 2 of PAX5 Gene in the Patients With Acute Lymphoblastic Leukemia Disease

Shokoufeh Yazdanparast 1 , Saeid Reza Khatami 1 , * , Hamid Galehdari 1 , Ahmad Ahmadzadeh 2 and Kaveh Jaseb 2
Authors Information
1 Department of Genetic, Faculty of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, IR Iran
2 Research Center of Thalassemia and Hemoglobinopathy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: May 31, 2016, 18 (5); e6670
  • Published Online: May 16, 2016
  • Article Type: Research Article
  • Received: December 9, 2014
  • Accepted: January 31, 2015
  • DOI: 10.17795/zjrms-6670

To Cite: Yazdanparast S, Khatami S R, Galehdari H, Ahmadzadeh A, Jaseb K. Variant Study in the Introns 1 and 2 of PAX5 Gene in the Patients With Acute Lymphoblastic Leukemia Disease, Zahedan J Res Med Sci. 2016 ; 18(5):e6670. doi: 10.17795/zjrms-6670.

Copyright © 2016, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Mullighan CG, Willman CL. Advances in the Biology of Acute Lymphoblastic Leukemia-From Genomics to the Clinic. J Adolesc Young Adult Oncol. 2011; 1(2): 77-86[DOI][PubMed]
  • 2. Redaelli A, Laskin BL, Stephens JM, Botteman MF, Pashos CL. A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL). Eur J Cancer Care (Engl). 2005; 14(1): 53-62[DOI][PubMed]
  • 3. Downing JR, Mullighan CG. Tumor-specific genetic lesions and their influence on therapy in pediatric acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program. 2006; : 118-22[DOI][PubMed]
  • 4. Figueroa ME, Chen SC, Andersson AK, Phillips LA, Li Y, Sotzen J, et al. Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia. J Clin Invest. 2013; 123(7): 3099-111[DOI][PubMed]
  • 5. Rahimi Z, Rahimi Z, Akramipour R. Prothrombin G20210A Mutation is not a Risk Factor for Pediatric Acute Lymphoblastic Leukemia in Western Iran. Middle East Journal of Cancer. 2013; 4(4): 139-43
  • 6. Teitell MA, Pandolfi PP. Molecular genetics of acute lymphoblastic leukemia. Annu Rev Pathol. 2009; 4: 175-98[DOI][PubMed]
  • 7. Meijerink JP, den Boer ML, Pieters R. New genetic abnormalities and treatment response in acute lymphoblastic leukemia. Semin Hematol. 2009; 46(1): 16-23[DOI][PubMed]
  • 8. Medvedovic J, Ebert A, Tagoh H, Busslinger M. Pax5: a master regulator of B cell development and leukemogenesis. Adv Immunol. 2011; 111: 179-206[DOI][PubMed]
  • 9. He T, Hong SY, Huang L, Xue W, Yu Z, Kwon H, et al. Histone acetyltransferase p300 acetylates Pax5 and strongly enhances Pax5-mediated transcriptional activity. J Biol Chem. 2011; 286(16): 14137-45[DOI][PubMed]
  • 10. Arseneau JR, Laflamme M, Lewis SM, Maicas E, Ouellette RJ. Multiple isoforms of <italic>PAX5</italic> are expressed in both lymphomas and normal B-cells. Br J Haematol. 2009; 147(3): 328-38[DOI][PubMed]
  • 11. Iacobucci I, Lonetti A, Paoloni F, Papayannidis C, Ferrari A, Storlazzi CT, et al. The <italic>PAX5</italic> gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party. Haematologica. 2010; 95(10): 1683-90[DOI][PubMed]
  • 12. McManus S, Ebert A, Salvagiotto G, Medvedovic J, Sun Q, Tamir I, et al. The transcription factor Pax5 regulates its target genes by recruiting chromatin-modifying proteins in committed B cells. EMBO J. 2011; 30(12): 2388-404[DOI][PubMed]
  • 13. Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007; 446(7137): 758-64[DOI][PubMed]
  • 14. Familiades J, Bousquet M, Lafage-Pochitaloff M, Bene MC, Beldjord K, De Vos J, et al. <italic>PAX5</italic> mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and <italic>PAX5</italic> haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study. Leukemia. 2009; 23(11): 1989-98[DOI][PubMed]
  • 15. Faustino NA, Cooper TA. Pre-mRNA splicing and human disease. Genes Dev. 2003; 17(4): 419-37[DOI][PubMed]
  • 16. Najjar Sadeghi R, Damavand B, Vahedi M, Mohebbi SR, Zojazi H, Molaei M, et al. Detection of p53 common intron polymorphisms in patients with gastritis lesions from Iran. Asian Pac J Cancer Prev. 2013; 14(1): 91-6[PubMed]
  • 17. Majewski J, Ott J. Distribution and characterization of regulatory elements in the human genome. Genome Res. 2002; 12(12): 1827-36[DOI][PubMed]
  • 18. Fitzsimmons D, Lukin K, Lutz R, Garvie CW, Wolberger C, Hagman J. Highly cooperative recruitment of Ets-1 and release of autoinhibition by Pax5. J Mol Biol. 2009; 392(2): 452-64[DOI][PubMed]
  • 19. Blake JA, Ziman MR. Pax genes: regulators of lineage specification and progenitor cell maintenance. Development. 2014; 141(4): 737-51[DOI][PubMed]
  • 20. O'Brien P, Morin PJ, Ouellette RJ, Robichaud GA. The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease. Cancer Res. 2011; 71(24): 7345-50[DOI][PubMed]
  • 21. An Q, Wright SL, Konn ZJ, Matheson E, Minto L, Moorman AV, et al. Variable breakpoints target <italic>PAX5</italic> in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer. Proc Natl Acad Sci U S A. 2008; 105(44): 17050-4[DOI][PubMed]
  • 22. Coyaud E, Struski S, Prade N, Familiades J, Eichner R, Quelen C, et al. Wide diversity of <italic>PAX5</italic> alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study. Blood. 2010; 115(15): 3089-97[DOI][PubMed]
  • 23. Zwollo P, Arrieta H, Ede K, Molinder K, Desiderio S, Pollock R. The Pax-5 gene is alternatively spliced during B-cell development. J Biol Chem. 1997; 272(15): 10160-8[PubMed]
  • 24. Arenas M, Duley J, Sumi S, Sanderson J, Marinaki A. The ITPA c.94C&gt;A and g.IVS2+21A&gt;C sequence variants contribute to missplicing of the ITPA gene. Biochim Biophys Acta. 2007; 1772(1): 96-102[DOI][PubMed]
  • 25. Harland M, Mistry S, Bishop DT, Bishop JA. A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees. Hum Mol Genet. 2001; 10(23): 2679-86[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments